The root bark from the Tabernanthe Iboga shrub, that grows in Central West Africa, particularly in Gabon, has been used for thousands of years in ceremonial rituals of the Bwiti tribe. Ibogaine is a substance that occurs naturally in the root bark of this shrub and used as a medication to assist patients in rehab centers with drug withdrawal symptoms.
The anti-addictive properties of Ibogaine have demonstrated an interruption of the symptoms of drug withdrawal and a reduction of craving for extended periods, allowing detoxification to take place with a minimum of discomfort. It appears that it has the ability to reset the neurotransmitter function of the brain to a state prior to addiction. Ibogaine is once again undergoing FDA approved clinical trials at the University of Miami.
Ibogaine is not available in the US except at Pangeo Biomedics where they administer ibogaine hydrocholoride, which is 98% pure, only under the care of a physician as part of clinical trials. Because it is a psychedelic drug, the effects are described as “dream creating”. The addict under the influence of Ibogaine is partially asleep, while being in a dream state, which they sometimes describe as watching themselves performing in a movie.
WHAT ARE THE EFFECTS OF IBOGAINE?
Ibogaine is anti-addictive, affecting the same neurotransmitter receptors as addictive drugs. Diminished withdrawal symptoms are the main effects when administering Ibogaine. After treatment with Ibogaine, some patients report that they feel better able to deal with certain issues that have burdened them for a long time, which puts them in a state where they become more cooperative to therapy. There have also been reports of significant changes in compulsive behavior.
The ingestion of Ibogaine causes patients to experience vivid visual phenomena. Some report sleeping through the whole experience while others see flashing lights and encounter an influx of rapid thoughts. Some report that they are able to organize their thoughts almost as though they were filing them away in a filing cabinet.
The metabolization of Ibogaine in the liver an active metabolite, noroibogaine, is formed which will stay in the system for up to six weeks. Norigogaine is what decreased the post- withdrawal symptoms and cravings, and may contain properties that are anti-depressive. This is the result of complex interaction between several neurotransmitters causing psychedelic actions in the brain.
Usually only a single dosage is necessary to effectively interrupt the effects of addiction to methamphetamine and cocaine, significantly reducing subsequent cravings for the drugs for a considerable period of time, which varies depending on the patient.
HOW DOES IT WORK:
Ibogaine is broken down in the liver into the metabolic nor-ibogaine, which has multiple actions on the nervous system. It remains in the body for several weeks after ingestion, preventing cravings and preventing the possibility of relapse.
The visual effects are particularly therapeutic and help to stimulate the desire for change as patients see themselves and their old patters clearly. As they come to terms with their past experiences, without the resultant emotional pain which normally accompanies those memories, they are motivated to find a better way to live their lives. Used with the proper supervision, Ibogaine can be a lifesaver to some addicts